Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Scand J Immunol ; 70(2): 101-5, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19630915

ABSTRACT

Transfusion of blood may contribute to immunomodulation. Leuco-depleted standard blood products are supposed to result in less immunomodulation compared with whole blood. To determine the influence of leuco-depleted blood products on the cytokine response, red blood cell concentrates (RBC), fresh frozen plasma (FFP) and platelet concentrates (PC) were investigated in an in vitro model of blood transfusion. Leuco-depleted standard blood bank RBC, FFP and PC were mixed in vitro with AB0 compatible venous blood from healthy volunteers in ratios of 3:1, 1:1 and 1:3. Specimens were incubated in presence or absence of lipopolysaccharide, 1 mug/ml. After 24 h of incubation cytokine release of tumour necrosis factor (TNF)-alpha and interleukin-10 (IL-10) was measured in cell culture supernatants by means of enzyme-linked immunsorbent assay. Addition of RBC, FFP and PC to venous blood from healthy volunteers led to a significant and dose-dependent increase in spontaneous TNF-alpha and IL-10 release. After endotoxin stimulation, RBC, FFP and PC significantly suppressed the TNF-alpha response, while the stimulated release of IL-10 tended to increase, reaching significance only after high doses of FFP. Addition of leuco-depleted blood products changed the spontaneous and stimulated cytokine response in an in vitro model of transfusion. These data may suggest a possible contribution of transfused FFP and PC to immunomodulation after transfusion similar to RBC.


Subject(s)
Blood Component Transfusion , Blood Platelets/immunology , Erythrocytes/immunology , Plasma/immunology , Blood Platelets/metabolism , Erythrocytes/metabolism , Humans , Interleukin-10/agonists , Interleukin-10/blood , Lipopolysaccharides/pharmacology , Models, Biological , Plasma/metabolism , Tumor Necrosis Factor-alpha/blood , Tumor Necrosis Factor-alpha/drug effects
2.
Anaesthesist ; 56(3): 232-5, 2007 Mar.
Article in German | MEDLINE | ID: mdl-17221261

ABSTRACT

Due to the high risk of perioperative adverse events, elective surgery should be suspended for at least 4 weeks after myocardial infarction and coronary stent revascularization, as current guidelines suggest. This report describes the successful management of a patient who underwent urgent surgery for a displaced hip fracture immediately after stent revascularization of an acute myocardial infarction. No new perioperative ischemia was detected. The therapeutic options and the timing of surgical procedures after stent revascularization are discussed.


Subject(s)
Angioplasty, Balloon, Coronary , Arthroplasty, Replacement, Hip , Hip Fractures/complications , Hip Fractures/surgery , Myocardial Infarction/complications , Myocardial Infarction/surgery , Myocardial Revascularization , Stents , Acute Disease , Aged , Anesthesia , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...